JP Morgan Private Wealth Advisors’s Kura Oncology KURA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q3
Sell
-29,500
Closed -$537K 1601
2018
Q2
$537K Hold
29,500
﹤0.01% 986
2018
Q1
$553K Hold
29,500
﹤0.01% 840
2017
Q4
$451K Hold
29,500
﹤0.01% 903
2017
Q3
$441K Hold
29,500
﹤0.01% 893
2017
Q2
$274K Hold
29,500
﹤0.01% 1051
2017
Q1
$260K Hold
29,500
﹤0.01% 1133
2016
Q4
$174K Buy
+29,500
New +$158K ﹤0.01% 1179

Other funds holding KURA

JP Morgan Private Wealth Advisors's KURA Position: Q3 2018 in Review

JP Morgan Private Wealth Advisors sold out of Kura Oncology (KURA) in Q3 2018, closing a stake of 29,500 shares — an estimated $537K sold.

JP Morgan Private Wealth Advisors first reported a position in KURA in Q4 2016 and held it in 7 quarters. The position peaked at $553K in Q1 2018. 116 funds tracked by Wall St. Rank hold KURA as of Q3 2018.

  • JP Morgan Private Wealth Advisors reported no remaining Kura Oncology position as of Q3 2018 after selling out during the quarter.
  • JP Morgan Private Wealth Advisors sold 29,500 Kura Oncology shares in Q3 2018, an estimated $537K.
  • JP Morgan Private Wealth Advisors first reported a position in Kura Oncology in Q4 2016 and held it in 7 quarters.
  • JP Morgan Private Wealth Advisors's Kura Oncology position peaked at $553K in Q1 2018.
  • 116 funds tracked by Wall St. Rank held Kura Oncology as of Q3 2018.

Based on JP Morgan Private Wealth Advisors's 13F filing for Q3 2018, filed 13 Nov 2018.